Filter
288
Filtered Results: 288
Text search:
subclinical
Featured
Recommendations
31
New Publications
63
Language
Document type
No document type
154
Guidelines
59
Studies & Reports
41
Manuals
14
Fact sheets
8
Strategic & Response Plan
6
Situation Updates
3
Training Material
2
Infographics
1
Countries / Regions
India
18
Western and Central Europe
11
South Africa
11
Latin America and the Carribbean
10
Nepal
9
Global
7
Paraguay
7
Malawi
5
Philippines
5
Africa
5
Namibia
5
Kenya
4
Eastern Europe
4
Colombia
3
Senegal
3
Argentina
3
Uganda
3
Brazil
3
Ukraine
2
Cameroon
2
Mozambique
2
Tanzania
2
Germany
2
Middle East and North Africa
2
Bolivia
2
Bangladesh
2
Angola
2
Zambia
2
Myanmar / Burma
2
Eswatini/ Swaziland
2
Pakistan
2
El Salvador
1
Lesotho
1
Turkey
1
Ghana
1
Sierra Leone
1
Rwanda
1
Chile
1
Syria
1
Nigeria
1
Albania
1
Afghanistan
1
Zimbabwe
1
USA
1
Asia
1
Venezuela
1
Congo, Democratic Republic of
1
West and Central Africa
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Portugal
1
East and Southern Africa
1
Papua New Guinea
1
Russia
1
Ethiopia
1
South Sudan
1
Indonesia
1
Iraq
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
105
Clinical Guidelines
40
Public Health
18
Key Resources
13
Women & Child Health
8
Capacity Building
2
Pharmacy & Technologies
1
Toolboxes
Mental Health
27
NTDs
27
COVID-19
25
HIV
20
TB
20
Planetary Health
12
NCDs
12
AMR
12
Rapid Response
5
Caregiver
3
Zika
3
Global Health Education
3
Conflict
2
Polio
2
Specific Hazards
1
Refugee
1
Cholera
1
Ebola & Marburg
1
Social Ethics
1
Health Financing Toolbox
1
Despite improvements in recent years, the prevalence of undernutrition among women and children in Myanmar remains unacceptably high. One in three children are stunted and about 8% are acutely malnourished. Micronutrient deficiencies are common among infants, young children and pregnant women. In fa...
This new publication presents the continuing and emerging challenges to children’s environmental health.
Therapeutics Information and Pharmacovigilance Centre | TIPC
Evidence-to-Decision and Grade tables
WHO TRS N°1012.
Key updates include: (i) surveillance strategies, including cross-sectoral linking of systems and suitable diagnostics; (ii) the latest recommendations on human and animal immunization; (iii) palliative care in lowresource settings; (iv) risk assessment to guide management of bite...
This publication is an updated version of the Management of Tuberculosis and HIV Coinfection clinical protocol released in 2007 by the WHO Regional Office for Europe. It is intended for all health care workers involved in preventing, diagnosing, treating and caring for people living with TB and HIV ...
Monitoring of implementation of collaborative TB/HIV activities and evaluation of impact is critically important. This requires efficient monitoring and evaluation system so as to establish accountability mechanisms between programmes, the population they serve, and donors. The Guide to monitoring a...
Accessed November 2017
Diabetes mellitus is a major cause of morbidity and mortality in Scotland and worldwide, with an increasing prevalence. In 2009 there were around 228,000 people registered as having diabetes in Scotland, an increase of 3.6% from the preceding year. This increase relates, in part, to the increasing a...
Diabetes is a major public health problem. The rising incidence of Diabetes Type 2 is related to the effects of urbanization and unhealthy lifestyles. Research studies show that healthy eating and regular physical activity can prevent or delay the onset of Diabetes Type 2, even in high-risk individu...
The roadmap describes the actions needed to
achieve the three development goals for TB
vaccines set by the WHO:
1. A safe, effective and affordable TB vaccine
for adolescents and adults.
2. An affordable TB vaccine for neonates and
infants with improved safety and efficacy.
3. A therapeutic v...
Version 10.1_5 October 2020
These Guidelines are available in different formats: As a paper booklet, a PDF, a mobile app, and now also as a website.
The 2019 version of the Guidelines introduces a new drug-drug interaction panel and now consists of six main sections, including a general overview ...
22 July 2022. This document summarizes current WHO guidance for public health surveillance of coronavirus disease 2019 (COVID-19) in humans caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
The cardiovascular disease continuum begins with risk factors such as diabetes mellitus (DM), progresses to vasculopathy and myocardial dysfunction, and finally ends with cardiovascular death. Diabetes is associated with a 2- to 4-fold increased risk for heart failure (HF). Moreover, HF patients wit...
Non-pharmaceutical interventions (NPI) are public health measures that aim to prevent and/or control SARS-CoV-2 transmission in the community. As long as there is no effective and safe vaccine to protect those at risk of severe COVID-19, NPI are the most effective public health interventions against...
